Protumorigenic Activity of Plasminogen Activator Inhibitor-1 Through an Antiapoptotic Function

Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

(2011) Eva J Kantelhardt et al.   BMC CANCER

Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor

(2010) Anne Masset et al.   INTERNATIONAL JOURNAL OF CANCER

The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling

(2009) Francesco Blasi et al.   FEBS LETTERS

Biochemical properties of plasminogen activator inhibitor-1

(2009) Daniel Miotto Dupont   Frontiers in Bioscience-Landmark

Low Density Lipoprotein Receptor-related Protein 1 Promotes Anti-apoptotic Signaling in Neurons by Activating Akt Survival Pathway

(2009) Rodrigo A. Fuentealba et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Impact of the Fibrinolytic System on the Risk of Venous and Arterial Thrombosis

(2009) Mirjam Meltzer et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Role of fibrinolysis in obesity and thrombosis

(2009) H.R. Lijnen   THROMBOSIS RESEARCH

Plasminogen Activator Inhibitor-1 Protects Endothelial Cells from FasL-Mediated Apoptosis

(2008) Khalid Bajou et al.   CANCER CELL

Evolving role of uPA/uPAR system in human cancers

(2008) Kathleen Dass et al.   CANCER TREATMENT REVIEWS

Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice

(2008) Michihiro Mutoh et al.   CARCINOGENESIS

Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors

(2008) C.M. Maillard et al.   CARCINOGENESIS